Antilipolytic drugs for the prevention of primary ventricular fibrillation-Reference-Cited by-同舟云学术

Antilipolytic drugs for the prevention of primary ventricular fibrillation

Published:2001-04 Issue:2 Volume:3 Page:61-65
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Oliver Michael F.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1463-1326.2001.00147.x/fullpdf

Reference32 articles.

1. Metabolic derangement in ischemic heart disease and its therapeutic control;Ferrari;Am J Cardiol,1998

2. Taegtmeyer , H Modulation of responses to myocardial ischemia: metabolic features of myocardial stunning, hibernation, and ischemic preconditioning Futura Publishing Co., Inc. 2000 25 35

3. A decade of clinical trials;Touboul;CAST to AVID. Eur Heart J,1999

4. Electropharmacological control of cardiac arrhythmias: to delay conduction or to prolong refractoriness;Singh;J Cardiovasc Electrophysiol,1994

5. Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction;Valori;Am J Cardiol,1967

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice;Cardiovascular Research;2012-07-10

2. High-dose insulin in experimental myocardial infarction in rabbits: protection against effects of hyperglycaemia;Journal of Diabetes and its Complications;2011-03

3. N-[3-(R)-Tetrahydrofuranyl]-6-aminopurine Riboside, an A1Adenosine Receptor Agonist, Antagonizes Catecholamine-Induced Lipolysis without Cardiovascular Effects in Awake Rats;Journal of Pharmacology and Experimental Therapeutics;2003-01-21

4. Current Awareness;Diabetes/Metabolism Research and Reviews;2001